Dr. Jaswinder Singh Rattan, MD

Dr. Rattan practices at Texas Kidney Consultants in Fort Worth, Texas.

Dr. Rattan's NPI, 1477708436, was assigned on November 18, 2008. Dr. Rattan graduated from Government Medical College Amritsar in 2000. Dr. Rattan holds Texas license Q6090.

Dr. Rattan's primary practice is Texas Kidney Consultants, at 2221 8th Ave, Fort Worth, TX 76110-1812. The practice phone is (817) 336-5060.

Dr. Rattan's primary practice is Texas Kidney Consultants in Fort Worth, Texas. Dr. Rattan is also affiliated with Texas Health Fort Worth. The medical group on file is Texas Kidney Consultants. Dmand AI also links Dr. Rattan to 4 more hospitals and 3 dialysis centers, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Rattan practices, 9 sites in all. Vendor and product names are available with a free account.

Nephrology is Dr. Rattan's primary specialty in the NPI Registry, under taxonomy code 207RN0300X. Dr. Rattan is board certified in internal medicine by the American Board of Internal Medicine. Dmand AI has Dr. Rattan's licenses on file in 6 states: Texas, Iowa, Georgia, Indiana, New York and South Carolina.

Dmand AI lists acute kidney failure, chronic kidney disease, fluid and electrolyte imbalances and parathyroid gland disorder among the conditions Dr. Rattan treats.

CMS data shows 2,431 Medicare services from Dr. Rattan across 13 procedure codes in 2024, for 636 Medicare patients. Medicare paid $242,009 for them.

CMS counts 636 Medicare patients who saw Dr. Rattan in 2024. The largest group is 75 to 84, with 208 patients. 75% of them have chronic kidney disease, and 75% have high blood pressure. 20% are also on Medicaid. Their average risk score is 4.37, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Rattan's median patient age at 67, with 45% women.

In 2024, Dr. Rattan wrote 2,849 Medicare Part D claims for 241 patients. 84% of them were for generic drugs. CMS names the drug for 2,416 of them, across 56 drugs with 11 or more claims each, at $240,202 in total drug cost. In 2023, CMS named 1,983 claims across 50 drugs.

Dr. Rattan accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 92 general payments to Dr. Rattan from 29 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 82% of the total. Amgen Inc. paid the most, $385.

Dr. Rattan graduated from Government Medical College Amritsar in 2000.

Dr. Rattan is in network with 22 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 13. Check the plan with the practice before a visit.